Immunoglobulin E-mediated anaphylaxis to rabeprazole.
Vovolis
V
V
Department of Allergy and Clinical Immunology, Laiko General Hospital, Athens, Greece. vasvovolis@gmail.com
Christogianni
K
K
Koutsostathis
N
N
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D000368:Aged; D000707:Anaphylaxis; D000799:Angioedema; D004115:Dimethindene / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology*; D010437:Peptic Ulcer / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D054328:Proton Pump Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011537:Pruritus; D064750:Rabeprazole; D012882:Skin Tests; D014474:Unconsciousness
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D054328:Proton Pump Inhibitors; D064750:Rabeprazole; D007073:Immunoglobulin E; D004115:Dimethindene; D006854:Hydrocortisone